Liver cancer linked to obesity, diabetes, higher BMI : cbsnews

as mentioned in cbsnews

Liver cancer linked to obesity, diabetes, higher BMI

Liver cancer linked to obesity, diabetes, higher BMI

Having a large waistline, a high body mass index (BMI) and type 2 diabetes, may raise your risk for liver cancer, a new study suggests."We found that each of these three factors was associated, robustly, with liver cancer risk," said study co-author Peter Campbell.He's strategic director of digestive system cancer research at the American Cancer Society.Liver cancer rates have roughly tripled in the United States since the mid-1970s, "and the prognosis for patients diagnosed with this type of cancer is especially grim," Campbell said.


let alone wsaw

Common prostate cancer treatment linked to dementia risk

Common prostate cancer treatment linked to dementia risk

A new study is adding to the evidence that a common prostate cancer treatment may raise a man's risk for dementia.Researchers from the University of Pennsylvania and Stanford found that a type of hormone therapy called androgen deprivation therapy (ADT) may double the risk of developing dementia.ADT is used to reduce levels of male hormones called androgens in the body and helps shrink prostate cancers.Androgens, including testosterone, stimulate the growth of prostate cancer cells.


besides stanford

Common prostate cancer treatment linked to later dementia, researcher says

Common prostate cancer treatment linked to later dementia, researcher says

The team looked at deidentified records from Stanford Medicine's clinical-research data warehouse for nearly 10,000 patients with prostate cancer.Of the 1,829 who received androgen deprivation therapy, 7.9 percent developed dementia within five years, compared with 3.5 percent of those not treated with ADT."The risk is real and, depending on the prior dementia history of the patient, we may want to consider alternative treatment, particularly in light of a recent prospective study from the U.K.," said Shah.That study, published in September in The New England Journal of Medicine, revealed that prostate cancer patients randomized to either active monitoring, surgery or radiation therapy all had the same risk of death from the cancer after 10 years.